FindTrial
Sign In

The optimal dose of dexmedetomidine for reduce the postoperative catheter-related bladder discomfort in post-anesthesia care unit PACU

The optimal dose of dexmedetomidine for reduce the postoperative catheter-related bladder discomfort in post-anesthesia care unit PACU

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200058415
Enrollment
Unknown
Registered
2022-04-09
Start date
2022-03-10
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Catheter-related bladder discomfort

Interventions

Intervention group:Dexmedetomidine

Sponsors

The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. American Society of Anesthesiologists (ASA) I-II; 2. Patients between 18 and 80 years in the PACU after general anesthesia; 3. Diagnosed Catheter-related bladder discomfort.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of bladder outflow obstruction, urinary tract infection, neurogenic bladder, chronic analgesic abuse, severe hepatic or renal disease, arrhythmia, and morbid obesity.

Design outcomes

Primary

MeasureTime frame
Severity of Catheter-related bladder discomfort;—

Secondary

MeasureTime frame
Adverse effects;—

Countries

China

Contacts

Public ContactJi Liting

The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital

jill23liitng@163.com+86 13587107221

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026